High myocardial 18F-FDG uptake after chemotherapy in the presence of left ventricular dysfunction as well as 3-month later with no left ventricular dysfunction

Document Type: Case Report

Authors

1 Division of Cardiology, Department of Internal Medicine, School of Medicine, Jeju National University, Jeju, Republic of Korea

2 Department of Pathology, School of Medicine, Jeju National University, Jeju, Republic of Korea

3 Department of Nuclear Medicine, School of Medicine, Jeju National University, Jeju, Republic of Korea

Abstract

Diffusely increased glucose metabolic activity in the right and left ventricles using 2-deoxy-2-(F-18) fluoro-D-glucose positron emission tomography/computed tomography (18F-FDGPET/CT) and global left ventricular hypokinesia at echocardiography can be evident in acute myocarditis. But, there has been no case report that the ventricular 18F-FDGuptake remains unchanged even after recovery of ventricular hypokinesia. A 60-year-old female with primary pleural effusion lymphoma underwent echocardiography and electrocardiography due to fever and elevated cardiac marker after chemotherapy. The electrocardiography showed global hypokinesia suggesting heart failure and the managements were performed. After 20 days 18F-FDGPET/CT for assessing the extent of lymphoma demonstrated that newly appeared high 18F-FDGuptake in the myocardium suggesting pathologic lesions. To evaluate malignancy a cardiac biopsy was performed. Myocarditis was confirmed pathologically. Three months later, improved ventricular function was confirmed by echocardiography, but the metabolic activity in the ventricles was not decreased at follow-up 18F-FDGPET/CT.

Keywords

Main Subjects


  1. Jingu K, Kaneta T, Nemoto K, Ichinose A, Oikawa M, Takai Y, Ogawa Y, Nakata E, Sakayauchi T, Takai K, Sugawara T, Narazaki K, Fukuda H, Takahashi S, Yamada S. The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):845-51.
  2. Volkova M, Russell R 3rd. Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev. 2011 Nov;7(4):214-20.
  3. James OG, Christensen JD, Wong TZ, Borges-Neto S, Koweek LM. Utility of FDG PET/CT in inflammatory cardiovascular disease. Radiographics. 2011 Sep-Oct;31(5):1271-86.
  4. Takano H, Nakagawa K, Ishio N, Daimon M, Daimon M, Kobayashi Y, Hiroshima K, Komuro I. Active myocarditis in a patient with chronic active Epstein-Barr virus infection. Int J Cardiol. 2008 Oct 30;130(1):e11-3.
  5. Maurer AH, Burshteyn M, Adler LP, Steiner RM. How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT. Radiographics. 2011 Sep-Oct;31(5):1287-305.
  6. Miyagawa M, Yokoyama R, Nishiyama Y, Ogimoto A, Higaki J, Mochizuki T. Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases. Circ J. 2014;78(6):1302-10.
  7. Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 2010 Jan 6;102(1):14-25.
  8. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation. 2005 Feb 22;111(7):887-93.
  9. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006 Feb 14;113(6):876-90.
  10. Fukuchi K, Ohta H, Matsumura K, Ishida Y. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies. Br J Radiol. 2007 Jan;80(949):3-11.